A new combination of two different approaches — virotherapy and immunotherapy — is showing ‘great promise’ as a treatment for pancreatic cancer, according to new research. The study investigated whether the effectiveness of the Vaccinia oncolytic virus — a virus modified to selectively infect and kill cancer cells — as a treatment for pancreatic cancer, would be improved by arming it with a gene which modulates the body’s immune system.